Showing 3,281 - 3,300 results of 18,785 for search 'significantly ((((((lower decrease) OR (we decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.86s Refine Results
  1. 3281
  2. 3282
  3. 3283
  4. 3284
  5. 3285
  6. 3286
  7. 3287
  8. 3288
  9. 3289
  10. 3290
  11. 3291
  12. 3292

    Raw images.pdf. by Longhai Li (4052044)

    Published 2025
    “…Meanwhile, CyclinA2 and CDK2 were significantly reduced after FAM50A knocking down.…”
  13. 3293

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…Meanwhile, CyclinA2 and CDK2 were significantly reduced after FAM50A knocking down.…”
  14. 3294
  15. 3295
  16. 3296
  17. 3297

    Periodic Open Cellular Structures with Streamlined Elliptical Struts for the Intensification of Mass Transfer-Limited Catalytic Reactors by Claudio Ferroni (10972436)

    Published 2025
    “…Decreasing α results in a streamlined structure with a reduced friction factor and a reduced transport coefficient, consistent with previous observations for POCS with circular struts. …”
  18. 3298

    Multistimuli-Responsive Porous Organic Polymers for Drug-Gas Anticancer Combination Therapy by Tina Skorjanc (4230178)

    Published 2025
    “…Herein, we use a porous organic polymer (POP) as a design strategy to prepare a combination therapy vehicle with spatially segregated gas and drug loading sites. …”
  19. 3299

    Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury by Jiahui Cheng (6056966)

    Published 2025
    “…However, low-immunogenic therapeutic strategies targeting the compromised immune-metabolic microenvironment remain a major challenge. Here, we developed a syngenic reparative macrophage system for the selective delivery of nanoscale drugs by modifying liposomes loaded with nano-Pt/Se and c176 onto the surface of M2 macrophages (PS-c@M). …”
  20. 3300

    Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury by Jiahui Cheng (6056966)

    Published 2025
    “…However, low-immunogenic therapeutic strategies targeting the compromised immune-metabolic microenvironment remain a major challenge. Here, we developed a syngenic reparative macrophage system for the selective delivery of nanoscale drugs by modifying liposomes loaded with nano-Pt/Se and c176 onto the surface of M2 macrophages (PS-c@M). …”